New agents are warranted in poor-prognosis DLBCL patients; the receptor tyrosine kinase ROR1 is absent in most normal adult tissues but overexpressed in several malignancies including DLBCL. Here, NTRK1 is linked to diffuse large B-cell lymphoma.